Effects of Diabetes Duration on Cardiorenal Efficacy of GLP-1 Analogs
Liraglutide and semaglutide demonstrated cardiorenal efficacy regardless of diabetes duration.
Cardiovascular Disease
Prasugrel Compared With Ticagrelor in Patients With ACS Undergoing PCI
A systematic review compared the safety and efficacy of prasugrel and ticagrelor in patients with ACS undergoing PCI.
High-Risk HPV May Be Associated With Cardiovascular Disease in Women
High-risk human papillomavirus infection may be associated with the risk for cardiovascular disease in Korean women.
High-Quality, Plant-Based Diet Tied to Lower Risk for CVD Mortality
No association seen for quality of plant-based diet and cancer-related deaths.
Cardiovascular Risk Increased During Gender Transition Process
People receiving hormone therapy during gender transition have an increased risk for cardiovascular events.
Clinical Apps Increase Quality of Care for Stable Ischemic Heart Disease
The use of multiple clinical apps in the outpatient clinic can improve quality of care for patients with stable ischemic heart disease.
Coexisting Medical Conditions, Smoking May Explain PTSD-CVD Link
The correlation between PTSD and CVD is not independent and is explained by physical and psychiatric conditions and smoking.
Empagliflozin May Reduce Cardiovascular Mortality in T2D With LVH
For patients with T2D and left ventricular hypertrophy, empagliflozin reduced the risk for cardiovascular death vs placebo.
Higher Exposure to CVD Risk Factors in Women vs Men Who Have Diabetes
Compared with men, women in whom diabetes develops experience greater changes in the cumulative burden of cardiovascular risk factors from young to middle-age adulthood, which may contribute to a higher risk for CVD events.
Aspirin Reduces CV Event Risk in Individuals Without Cardiovascular Disease
The use of aspirin was associated with a lower risk for cardiovascular events in individuals without cardiovascular disease.
Next post in Prevention
